Transcriptional Silencing Of Foxd3 Is An Early Event Mediating Epigenetic Silencing In Tcl1 Positive Chronic Lymphocytic Leukemia
Main Author: | Chen, Shih-Shih |
---|---|
Language: | English |
Published: |
The Ohio State University / OhioLINK
2008
|
Subjects: | |
Online Access: | http://rave.ohiolink.edu/etdc/view?acc_num=osu1214923446 |
Similar Items
-
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia
by: Thomas Parigger, et al.
Published: (2021-06-01) -
T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
by: Francesco Paduano, et al.
Published: (2018-08-01) -
FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
by: Gui-fang Luo, et al.
Published: (2019-02-01) -
Tcl/Tk
by: Pönisch, Jens
Published: (2000) -
FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2
by: Yang Chen, et al.
Published: (2021-08-01)